Somewhat Positive News Coverage Somewhat Unlikely to Affect HealthEquity (NASDAQ:HQY) Share Price
News coverage about HealthEquity (NASDAQ:HQY) has trended somewhat positive recently, according to Accern. Accern rates the sentiment of media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. HealthEquity earned a news impact score of 0.09 on Accern’s scale. Accern also gave news coverage about the company an impact score of 45.6938869150325 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
These are some of the news articles that may have effected Accern Sentiment’s scoring:
- $0.14 EPS Expected for Healthequity Inc (HQY) (elcumanes.com)
- HealthEquity, Inc. (HQY) Stake Decreased by Stephens Investment Management Group LLC (overnewsmagazine.com)
- Head to Head Contrast: HealthEquity (HQY) and Press Ganey Holdings (PGND) (americanbankingnews.com)
- Stephens Investment Management Group LLC Sold A Little More HealthEquity, Inc. (HQY) Stock Last Quarter (highlightpress.com)
- HealthEquity Sets Date to Announce Second Quarter Results; Participation at Investor Healthcare Conferences (finance.yahoo.com)
A number of equities research analysts have recently weighed in on the stock. Cantor Fitzgerald lifted their price target on shares of HealthEquity from $50.00 to $55.00 and gave the company an “overweight” rating in a research report on Wednesday, June 7th. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and issued a $61.00 price target (up from $57.00) on shares of HealthEquity in a research report on Monday, June 12th. BidaskClub downgraded shares of HealthEquity from a “buy” rating to a “hold” rating in a research report on Monday, July 24th. Zacks Investment Research upgraded shares of HealthEquity from a “hold” rating to a “buy” rating and set a $54.00 price target for the company in a research report on Wednesday, July 12th. Finally, Chardan Capital lifted their price target on shares of HealthEquity from $53.00 to $57.00 and gave the company a “buy” rating in a research report on Wednesday, June 7th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $50.22.
Shares of HealthEquity (NASDAQ:HQY) traded down 2.62% on Friday, reaching $44.93. 579,253 shares of the company’s stock traded hands. The company’s 50-day moving average price is $48.74 and its 200 day moving average price is $46.12. The firm has a market cap of $2.69 billion, a P/E ratio of 84.45 and a beta of 1.73. HealthEquity has a one year low of $28.39 and a one year high of $54.95.
HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, June 6th. The company reported $0.19 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.16 by $0.03. HealthEquity had a net margin of 17.04% and a return on equity of 11.61%. The firm had revenue of $55.40 million during the quarter, compared to the consensus estimate of $54.77 million. During the same period last year, the firm earned $0.15 EPS. The business’s quarterly revenue was up 25.9% compared to the same quarter last year. On average, equities analysts forecast that HealthEquity will post $0.58 EPS for the current fiscal year.
In other HealthEquity news, VP Ashley Dreier sold 10,000 shares of the firm’s stock in a transaction on Monday, June 5th. The shares were sold at an average price of $47.81, for a total value of $478,100.00. Following the completion of the transaction, the vice president now directly owns 15,652 shares of the company’s stock, valued at approximately $748,322.12. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Stephen Neeleman sold 40,000 shares of the firm’s stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $48.36, for a total transaction of $1,934,400.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 2,440,821 shares of company stock valued at $125,325,268. Insiders own 29.00% of the company’s stock.
WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Affect HealthEquity (NASDAQ:HQY) Share Price” was posted by Watch List News and is the property of of Watch List News. If you are reading this story on another publication, it was illegally copied and republished in violation of U.S. and international copyright and trademark laws. The original version of this story can be viewed at https://www.watchlistnews.com/somewhat-positive-news-coverage-somewhat-unlikely-to-affect-healthequity-nasdaqhqy-share-price/1478387.html.
HealthEquity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.